Skip to content

The protective effects of butorphanol on pulmonary function in patients at intermediate to high risk of postoperative pulmonary complications

The protective effects of butorphanol on pulmonary function in patients at intermediate to high risk of postoperative pulmonary complications

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050312
Enrollment
Unknown
Registered
2021-08-26
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung protection

Interventions

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged>=18 years; 2.American Society of Anesthesiologists (ASA) classification I-III; 3.ARISCAT score >=26; 4.The postoperative length of stay is expected to exceed 24h; 5.Signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnancy or breastfeeding; 2.Severe functional liver and kidney disease; 3.Pulmonary disease including COPD, pulmonary infection,bronchiectasis and asthma; 4.Subjects has contraindication for butorphanol; 5.Abuse of opioids; 6.Mental illness and communication disorder before surgery; 7.Patients on ventilators before surgery.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative pulmonary complications;

Secondary

MeasureTime frame
Lung function and respiratory mechanical parameters;Quality of recovery;Intraoperative hemodynamic indexes and intraoperative cumulative opioid use;Unplanned admission to intensive care unit;The incidence of postoperative adverse reactions;Number of effective compressions of analgesic pump and cumulative use of sufentanil;Concentration of CC16, IL-6, IL-10, ICAM-1, ET-1;

Countries

China

Contacts

Public ContactLiu Su

The Affiliated Hospital of Xuzhou Medical University

150040009@qq.com+86 18118309692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026